Global healthcare company Abbott buys Vietnamese drug manufacturer (Photo: Abbott) HCM City (VNA) - Global healthcare company Abbott has announced that it had acquired Glomed Pharmaceutical Company Inc (Glomed), a leading Vietnamese drug manufacturer.
It did not disclose the financial details of the deal.
“This acquisition will further strengthen Abbott’s ability to serve patients in Vietnam with innovative, high-quality healthcare solutions that allow them to live a healthier life and reach their full potential,” said Ngo Van Huy, General Manager of Abbott’s pharmaceuticals business.
“The company intends to build on Glomed’s success to date to ensure long-term growth in the country.”
The expansion of Abbott’s drug business in Vietnam builds on its leading position in nutrition and a strong portfolio in medical devices and diagnostics.
The acquisition also makes Abbott one of the top 10 pharmaceutical companies in Vietnam.-VNA
